Beclomethasone Dipropionate Monohydrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 5 EU WC, 3 KDMF, 12 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers, 14 FDA Orange Book, 91 Europe, 7 Canada, 4 Australia, 14 South Africa, 34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 15 Solubilizers, 14 Direct Compression, 10 Co-Processed Excipients, 7 Parenteral, 6 Controlled & Modified Release, 6 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 5 Granulation, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Emulsifying Agents, 3 Taste Masking, 3 Topical, 2 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 2 Surfactant & Foaming Agents, 1 API Stability Enhancers